IRADIMED CORP - Common (IRMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q4 2025

Type / Class
Equity / Common
Symbol
IRMD on Nasdaq
Shares outstanding
12,602,265
Price per share
$98.30
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
7,399,363
Total reported value
$719,876,156
% of total 13F portfolios
0%
Share change
+508,985
Value change
+$50,633,803
Number of holders
214
Price from insider filings
$98.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IRADIMED CORP - Common (IRMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 3.9% $26,667,581 496,603 BlackRock, Inc. 31 Mar 2025
Nine Ten Capital Management LLC 3.4% -53% $42,119,289 -$46,933,237 428,477 -53% Nine Ten Capital Management 31 Dec 2025

As of 31 Dec 2025, 214 institutional investors reported holding 7,399,363 shares of IRADIMED CORP - Common (IRMD). This represents 59% of the company’s total 12,602,265 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of IRADIMED CORP - Common (IRMD) together control 44% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8% 1,001,999 -1.4% 0% $97,474,463
VANGUARD GROUP INC 4.4% 560,048 -1.1% 0% $54,481,469
RENAISSANCE TECHNOLOGIES LLC 3.6% 456,412 -6.6% 0.07% $44,399,759
Nine Ten Capital Management LLC 3.4% 428,477 -44% 13% $41,682,000
Copeland Capital Management, LLC 3.3% 412,550 -4.8% 0.9% $40,132,980
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 2.6% 333,229 0.09% $32,416,517
GEODE CAPITAL MANAGEMENT, LLC 2.1% 261,965 -1.6% 0% $25,487,645
T. Rowe Price Investment Management, Inc. 2% 255,887 +411% 0.02% $24,893,000
DIMENSIONAL FUND ADVISORS LP 1.7% 217,129 +1.2% 0% $21,122,616
GOLDMAN SACHS GROUP INC 1.6% 205,227 +37% 0% $19,964,482
STATE STREET CORP 1.5% 192,952 +3.1% 0% $18,770,371
ACADIAN ASSET MANAGEMENT LLC 1.2% 149,451 +2.9% 0.02% $14,529,000
MORGAN STANLEY 1.1% 134,731 +5.9% 0% $13,106,709
NORTHERN TRUST CORP 1% 132,045 -4% 0% $12,845,338
Ranger Investment Management, L.P. 0.88% 111,470 -6.8% 0.74% $10,843,802
Russell Investments Group, Ltd. 0.87% 109,185 +5.4% 0.01% $10,621,697
ALGERT GLOBAL LLC 0.68% 85,660 +69% 0.13% $8,333,000
Bank of New York Mellon Corp 0.68% 85,531 -17% 0% $8,320,495
Bridge City Capital, LLC 0.56% 70,854 +19% 2% $6,892,677
SG Americas Securities, LLC 0.56% 70,391 +89% 0.01% $6,848,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.54% 68,220 -0.39% 0% $6,636,442
FMR LLC 0.53% 66,732 +226% 0% $6,491,642
Uniplan Investment Counsel, Inc. 0.52% 65,695 -15% 0.64% $6,390,878
TWO SIGMA INVESTMENTS, LP 0.52% 64,914 +21% 0.01% $6,314,834
ENVESTNET ASSET MANAGEMENT INC 0.5% 63,424 -5.4% 0% $6,169,866

Institutional Holders of IRADIMED CORP - Common (IRMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 7,399,363 $719,876,156 +$50,633,803 $97.28 214
2025 Q3 6,912,935 $491,933,058 -$6,310,418 $71.16 183
2025 Q2 7,049,520 $421,491,084 +$6,336,536 $59.79 160
2025 Q1 6,961,071 $365,301,337 -$580,349 $52.48 167
2024 Q4 6,970,032 $383,359,036 +$9,147,980 $55.00 166
2024 Q3 6,774,947 $340,330,934 -$4,474,758 $50.29 144
2024 Q2 6,822,202 $299,786,808 +$3,892,743 $43.94 137
2024 Q1 6,716,470 $295,435,220 +$14,779,015 $43.99 125
2023 Q4 6,459,357 $306,655,798 +$17,489,557 $47.47 117
2023 Q3 6,101,541 $270,676,624 -$3,589,822 $44.37 113
2023 Q2 6,133,726 $292,922,488 +$17,028,601 $47.74 109
2023 Q1 5,780,603 $227,464,394 +$10,412,240 $39.35 90
2022 Q4 5,525,882 $156,321,831 -$3,249,669 $28.29 74
2022 Q3 5,606,466 $168,465,363 +$3,059,725 $30.06 81
2022 Q2 5,523,842 $187,480,258 +$1,615,681 $33.94 89
2022 Q1 5,372,509 $240,988,874 +$16,505,748 $44.84 101
2021 Q4 4,999,149 $230,849,125 +$7,127,231 $46.21 95
2021 Q3 4,725,811 $158,784,781 -$1,638,874 $33.59 71
2021 Q2 4,763,037 $140,116,293 +$1,376,586 $29.41 58
2021 Q1 4,729,017 $122,230,018 +$965,764 $25.77 52
2020 Q4 4,699,928 $107,178,220 +$4,636,145 $22.80 54
2020 Q3 4,517,233 $96,756,082 -$243,528 $21.38 61
2020 Q2 4,511,673 $104,727,212 +$10,282,835 $23.21 64
2020 Q1 4,085,698 $87,134,189 +$8,149,558 $21.35 68
2019 Q4 3,690,519 $86,285,753 +$10,150,433 $23.38 63
2019 Q3 3,030,091 $63,689,327 +$7,477,563 $21.02 57
2019 Q2 2,676,745 $54,735,507 +$671,270 $20.45 53
2019 Q1 2,623,653 $73,697,489 +$8,416,113 $28.09 64
2018 Q4 2,337,055 $57,160,517 -$411,877 $24.46 66
2018 Q3 2,247,761 $83,484,135 +$11,708,363 $37.15 68
2018 Q2 2,122,428 $44,038,752 +$5,588,999 $20.75 51
2018 Q1 1,710,580 $24,258,264 +$2,579,198 $14.13 34
2017 Q4 1,731,697 $26,254,559 +$2,439,990 $15.15 36
2017 Q3 1,459,156 $14,010,010 -$339,474 $9.60 27
2017 Q2 1,500,984 $12,902,009 -$2,639,238 $8.59 32
2017 Q1 1,798,934 $16,007,694 -$4,081,328 $8.90 45
2016 Q4 2,275,470 $25,256,786 -$7,709,765 $11.10 56
2016 Q3 2,605,006 $44,256,310 +$5,717,918 $16.99 60
2016 Q2 2,213,145 $48,158,183 -$10,186,916 $21.76 58
2016 Q1 2,833,006 $54,284,033 +$961,021 $19.16 64
2015 Q4 2,567,466 $71,964,026 +$36,452,591 $28.03 73
2015 Q3 1,286,850 $31,343,593 +$2,668,004 $24.36 45
2015 Q2 1,280,146 $29,788,794 -$1,342,477 $23.27 38
2015 Q1 1,300,950 $19,816,000 -$252,990 $15.23 20
2014 Q4 1,323,017 $17,067,000 -$360,502 $12.90 19
2014 Q3 1,372,532 $9,620,000 +$9,620,000 $7.01 16